Prime time for doxorubicin-induced cardiotoxicity genetic testing

Tarek Magdy, Paul W. Burridge*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)335-338
Number of pages4
JournalPharmacogenomics
Volume23
Issue number6
DOIs
StatePublished - Apr 2022

Keywords

  • cardiotoxicity
  • chemotherapy
  • clinical translation
  • human-induced pluripotent stem cells
  • pharmacogenomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Cite this